QIAGEN, DiaSorin get FDA nod for TB assay use on LIAISON XS platform
The additional approval enables QIAGEN and DiaSorin to provide a suite of automation platforms for TB testing options…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Nov 21
The additional approval enables QIAGEN and DiaSorin to provide a suite of automation platforms for TB testing options…
29 Nov 21
Eurofins, through Gold Standard Diagnostics Europe, provides the toolset to rapidly identify the variant B.1.1.529
26 Nov 21
Lunit is involved in the development of AI-powered diagnostic tools for cancer screening, as well as biomarkers to…
26 Nov 21
Designed to target the ORF1ab gene, the genesig Covid-19 assay holds the potential to identify all known variants…
26 Nov 21
The Prosigna assay is the only breast cancer genomic test that is both CE-IVD marked and recommended by…
26 Nov 21
The new national strategy will enable nasopharyngeal PCR tests to continue as primary diagnostic test, supported other testing…
25 Nov 21
The aim of the licence is to facilitate the rapid manufacture and commercialization of CSIC’s COVID-19 serological test…
24 Nov 21
With this investment, the Group strengthens its offer in point of care medical biology and positions itself in…
23 Nov 21
Detectx-Cv has also received domestic validation from Stanford Virology Lab, TriCorp Reference Labs and the University of Miami…
23 Nov 21
Lemon Medical offers viral and bacterial filters to protect patients, medical personnel, and diagnostic instruments from cross contamination…